Effect of Artronat on the Quality of Life of Patient With Osteoarthritis
The purpose of this study is to determine whether the nutritional supplement ARTRONAT improves the quality of life of patients with osteoarthritis.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator)
Primary Purpose: Supportive Care
|Official Title:||Effet du complément Alimentaire ARTRONAT(R) Sur la réduction de la Gonalgie Chez Des Sujets Arthrosiques|
- Reduction of gonalgia [ Time Frame: T8 months ] [ Designated as safety issue: No ]measure with the WOMAC.
- Evaluation of the satisfactory relief of symptoms of osteoarthritis at each visit after the beginning of supplementation, assessed by the patients. [ Time Frame: T2, T4, T6, T8 months ] [ Designated as safety issue: No ]Subjective global assessment measured on a 10-cm graduated scale (Visual Analogue Scale)
|Study Start Date:||October 2011|
|Study Completion Date:||December 2013|
|Primary Completion Date:||January 2013 (Final data collection date for primary outcome measure)|
Dietary Supplement: ARTRONAT
Dietary supplement containing Glucosamine, Chondroïtine and manganese. 6 per day for 8 months.
|Placebo Comparator: PLACEBO||
Dietary Supplement: PLACEBO
PLACEBO. 6 per day for 8 months.
Osteoarthritis is a degenerative disease that greatly impairs the quality of life of patients. A nutritional supplement may help, in association with the normal treatment of osteoarthritis, improving the quality of life of such patients, in reducing pain and/or improving join flexibility.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01356199
|Centre Rééducation et Réadaptation Fonctionnelles de Trestel , Centre Hospitalier Pierre-Le-Damany Lannion|
|Treviou Treguignec, France, 22660|
|Study Chair:||Maurice Cloarec, MD||Association Nationale de Prevention Medicale|
|Principal Investigator:||Dominique Baron, MD||Hospital Center of Lanion|